Literature DB >> 6470358

Urinary N tau-methylhistamine during early and late allergen-induced bronchial-obstructive reactions.

J J Keyzer, H F Kauffman, J G de Monchy, J J Keyzer-Udding, K de Vries.   

Abstract

Urinary N tau-methylhistamine, a unique histamine metabolite, was determined in 29 patients with bronchial asthma before and after inhalation of a control solution on 1 day and before and after allergen inhalation on another day. Twenty-eight patients had an early bronchial-obstructive reaction, defined by a decrease in FEV1 of 20% or more within 1 hr after allergen inhalation. A late bronchial-obstructive reaction, 3 to 8 hr after allergen inhalation, was found in 16 patients. The early bronchial-obstructive reaction was attended with a significantly increased N tau-methylhistamine excretion. The fall in FEV1 was correlated with the degree of bronchial hyperreactivity to histamine, but no significant correlation was found with the increase in urinary N tau-methylhistamine excretion. During the late reaction there was no significant difference in the change in N tau-methylhistamine excretion when the change was compared with that of the control day. These results suggest that a renewed degranulation of lung mast cells during the late bronchial-obstructive reaction is unlikely.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470358     DOI: 10.1016/0091-6749(84)90252-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Conjunctival provocative tests: a model of human ocular allergy.

Authors:  M H Friedlaender
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 2.  Late-phase IgE-mediated reactions.

Authors:  R F Lemanske; M Kaliner
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

3.  Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.

Authors:  A Freitag; R M Watson; G Matsos; C Eastwood; P M O'Byrne
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.